News
DRIO
1.160
+0.87%
0.010
Dario Signs Two Employers For Cardiometabolic Suite With Integrated GLP-1 Solution, Beginning In Q2 Of 2024
Benzinga · 1d ago
DARIOHEALTH CORP - TWO NEW CONTRACTS TO PROVIDE INTEGRATED CHRONIC CONDITION MANAGEMENT SOLUTIONS FOR TWO EMPLOYERS BEGINNING IN Q2 OF 2024
Reuters · 1d ago
Weekly Report: what happened at DRIO last week (0408-0412)?
Weekly Report · 5d ago
Weekly Report: what happened at DRIO last week (0401-0405)?
Weekly Report · 04/08 11:33
DarioHealth Raises CFO Zvi Ben-David’s Salary and Bonus Potential
TipRanks · 04/05 20:44
DarioHealth Is Maintained at Buy by Stifel
Dow Jones · 04/01 15:12
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA), DarioHealth (DRIO) and Accelerate Diagnostics (AXDX)
TipRanks · 04/01 12:40
Weekly Report: what happened at DRIO last week (0325-0329)?
Weekly Report · 04/01 11:30
DRIO Stock Earnings: DarioHealth Beats EPS, Beats Revenue for Q4 2023
DarioHealth reported earnings per share of -41 cents for the fourth quarter of 2023. The company reported revenue of $3.62 million. This was 1.29% better than the analyst estimate for revenue. DarioHealth also reported results for the third quarter of 2018.
Investorplace · 03/28 14:53
DarioHealth Corp reports results for the quarter ended in December - Earnings Summary
DarioHealth Corp reports results for the quarter ended in December. Revenue fell 46.9% to $3.62 million from a year ago. The company reported a quarterly adjusted loss of 50 cents per share. The mean expectation of three analysts was for a loss of 54 cents.
Reuters · 03/28 13:31
DarioHealth Q4 EPS $(0.41) Beats $(0.54) Estimate
Benzinga · 03/28 10:43
DarioHealth reports Q4 results
DarioHealth Corp. Reports Q4 results. Revenue of $3.6M (-47.1% Y/Y) misses by $0.18M. Q4 net loss excluding stock-based compensation was $8.4 million. Ended 2023 with cash and cash equivalents of $37 million.
Seeking Alpha · 03/28 10:39
DarioHealth Q4 Sales $3.62M Beat $3.57M Estimate
Benzinga · 03/28 10:35
Earnings Scheduled For March 28, 2024
Universal Stainless is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. Walgreens Boots Alliance is likely to report earnings for its fourth quarter. Companies Reporting Before The Bell include Shimmick and Universal Stainless. Companies reporting after the bell include INmune Bio and Oxford Industries.
Benzinga · 03/28 09:24
Pre-Market Earnings Report for March 28, 2024 : AFMD, ATAT, AWH, AZUL, CNF, DLNG, DOOO, DRIO, GROY, HUT, IMNN, ITRM
NASDAQ · 03/27 20:00
Earnings Outlook For DarioHealth
DarioHealth is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Analysts estimate the company will report an earnings per share of $-0.54. Last quarter the company missed EPS by $0.03. Shares of DarioHealth were trading at $1.515 as of March 26.
Benzinga · 03/27 17:00
Notable earnings before Thursday's open
Seeking Alpha · 03/27 13:11
DarioHealth Corp <DRIO.OQ> expected to post a loss of 54 cents a share - Earnings Preview
DarioHealth Corp expected to post a loss of 54 cents a share. The company is expected to report a 47.5% decrease in quarterly revenue to $3.572 million from $6.81 million.
Reuters · 03/26 12:46
Weekly Report: what happened at DRIO last week (0318-0322)?
Weekly Report · 03/25 11:33
Weekly Report: what happened at DRIO last week (0311-0315)?
Weekly Report · 03/18 11:31
More
Webull provides a variety of real-time DRIO stock news. You can receive the latest news about Dariohealth Corp through multiple platforms. This information may help you make smarter investment decisions.
About DRIO
DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.